Drug Type CAR-T |
Synonyms |
Target |
Action modulators |
Mechanism GOT2 modulators(glutamic-oxaloacetic transaminase 2 modulators), TIGAR modulators(TP53 induced glycolysis regulatory phosphatase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | 22 Mar 2024 |